Gerald has built AMBS, it's asset base, it's management team and has made AMBS one of the most watched new bio pharmaceutical companies. He has attracted analyst and raised enough capital to get the company to the point where they can execute. At the end of the day we are one step closer to moving our product line into the hands of the doctors where they can save lives.
Also, with the new cusip number the shorts have to cover. Hence that's why there is so much buying along with the selling.